{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:48:54Z","timestamp":1774529334928,"version":"3.50.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Collagenase clostridium histolyticum (CCH) is an Food and Drug Administration-approved intralesional injection for treatment of Peyronie\u2019s disease (PD) that has been shown to reduce penile curvature deformity and PD symptom bother in phase 2b and phase 3 placebo-controlled clinical trials. For some patients, nonsurgical treatment with CCH may not sufficiently improve penile curvature, and surgical correction may be pursued following CCH therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This study aims to examine intraoperative and postsurgical outcomes of surgical correction of persistent penile curvature in patients with PD who had previously received CCH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective chart review was used to identify patients with PD who had received CCH intralesional injection within either the phase 2b or phase 3 CCH clinical trials and then underwent surgical correction due to remaining penile curvature. Surgical techniques used were partial plaque excision and grafting (PEG) and\/or tunica albuginea plication (TAP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>Primary assessments included pre- and postsurgery penile curvature, erectile rigidity, stretched penile length, intraoperative time, and occurrence of adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven men were identified who underwent surgical straightening with TAP or PEG following CCH treatment. Mean number of days from the final CCH injection to surgery was 182 (standard deviation 118; median 127 days). Average penile curvature prior to surgical straightening was 58\u00b0. No anatomical difficulties or complications secondary to the effects of prior CCH treatment occurred during surgery. Intraoperative time was representative of standard TAP and PEG surgeries (range 88\u2013146 minutes). All men reported penile curvature &amp;lt;20\u00b0 postsurgery. One patient experienced a postsurgery subgraft hematoma that required aspiration. There were no postsurgery reports of decreased penile sexual sensation and no occurrence of vascular compromise or decreased penile rigidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This initial case series supports the hypothesis that prior CCH treatment is not a contraindication to PEG or TAP surgery in the treatment of penile curvature in patients with PD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jsm.12721","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T07:34:56Z","timestamp":1414395296000},"page":"259-264","source":"Crossref","is-referenced-by-count":35,"title":["Surgical Correction of Persistent Peyronie\u2019s Disease Following Collagenase Clostridium Histolyticum Treatment"],"prefix":"10.1093","volume":"12","author":[{"given":"Laurence A.","family":"Levine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Larsen","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Chicago, IL , USA"},{"name":"Rush University Medical Center \u00a0 , Chicago, IL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,1,1]]},"reference":[{"key":"2023010704091202200_bb0010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ucl.2007.08.017","article-title":"Peyronie\u2019s disease","volume":"34","author":"Taylor","year":"2007","journal-title":"Urol Clin North Am"},{"key":"2023010704091202200_bb0015","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1111\/j.1743-6109.2008.00883.x","article-title":"Impact of Peyronie\u2019s disease on sexual and psychosocial functioning: Qualitative findings in patients and controls","volume":"5","author":"Rosen","year":"2008","journal-title":"J Sex Med"},{"key":"2023010704091202200_bb0020","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1111\/j.1743-6109.2008.00895.x","article-title":"The chronology of depression and distress in men with Peyronie\u2019s disease","volume":"5","author":"Nelson","year":"2008","journal-title":"J Sex Med"},{"key":"2023010704091202200_bb0025","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/j.1743-6109.2008.00949.x","article-title":"Risk factors for emotional and relationship problems in Peyronie\u2019s disease","volume":"5","author":"Smith","year":"2008","journal-title":"J Sex Med"},{"key":"2023010704091202200_bb0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1743-6109.2012.03003.x","article-title":"Standard operating procedures for Peyronie\u2019s disease","volume":"10","author":"Levine","year":"2013","journal-title":"J Sex Med"},{"key":"2023010704091202200_bb0035","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11934-011-0212-2","article-title":"Treatment of Peyronie\u2019s disease: 2012 update","volume":"12","author":"Serefoglu","year":"2011","journal-title":"Curr Urol Rep"},{"key":"2023010704091202200_bb0040","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1517\/14656566.2011.544252","article-title":"Current status and new developments in Peyronie\u2019s disease: Medical, minimally invasive and surgical treatment options","volume":"12","author":"Gur","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"2023010704091202200_bb0045","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01850.x","article-title":"The management of Peyronie\u2019s disease: Evidence-based 2010 guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J Sex Med"},{"key":"2023010704091202200_bb0050","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1743-6109.2008.01081.x","article-title":"Peyronie\u2019s disease intervention trials: Methodological challenges and issues","volume":"6","author":"Muller","year":"2009","journal-title":"J Sex Med"},{"key":"2023010704091202200_bb0055","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.juro.2012.01.032","article-title":"Phase 2b study of clinical efficacy and safety of collagenase clostridium histolyticum in patients with Peyronie\u2019s disease","volume":"187","author":"Gelbard","year":"2012","journal-title":"J Urol"},{"key":"2023010704091202200_bb0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"2023010704091202200_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/aja.2012.92","article-title":"Surgery for Peyronie\u2019s disease","volume":"15","author":"Levine","year":"2013","journal-title":"Asian J Androl"},{"key":"2023010704091202200_bb0070","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0022-5347(01)68184-9","article-title":"A surgical algorithm for the treatment of Peyronie\u2019s disease","volume":"158","author":"Levine","year":"1997","journal-title":"J Urol"},{"key":"2023010704091202200_bb0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.ijir.3900515","article-title":"A surgical algorithm for penile prosthesis placement in men with erectile failure and Peyronie\u2019s disease","volume":"12","author":"Levine","year":"2000","journal-title":"Int J Impot Res"},{"key":"2023010704091202200_bb0080","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1743-6109.2005.20113.x","article-title":"A surgical algorithm for men with combined Peyronie\u2019s disease and erectile dysfunction: Functional and satisfaction outcomes","volume":"2","author":"Mulhall","year":"2005","journal-title":"J Sex Med"},{"key":"2023010704091202200_bb0085","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1743-6109.2011.02460.x","article-title":"Predicting erectile dysfunction following surgical correction of Peyronie\u2019s disease without inflatable penile prosthesis placement: Vascular assessment and preoperative risk factors","volume":"9","author":"Taylor","year":"2012","journal-title":"J Sex Med"},{"key":"2023010704091202200_bb0090","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/j.1743-6109.2011.02299.x","article-title":"Erectile dysfunction after plaque incision and grafting: Short-term assessment of incidence and predictors","volume":"8","author":"Flores","year":"2011","journal-title":"J Sex Med"},{"key":"2023010704091202200_bb0095","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/bi00377a004","article-title":"Limited proteolysis of type I collagen at hyperreactive sites by class I and II Clostridium histolyticum collagenases: Complementary digestion patterns","volume":"26","author":"French","year":"1987","journal-title":"Biochemistry"},{"key":"2023010704091202200_bb0100","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0363-5023(96)80368-6","article-title":"Collagenase in the treatment of Dupuytren\u2019s disease: An in vitro study","volume":"21","author":"Starkweather","year":"1996","journal-title":"J Hand Surg [Am]"},{"key":"2023010704091202200_bb0105","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren\u2019s contracture","volume":"361","author":"Hurst","year":"2009","journal-title":"N Engl J Med"},{"key":"2023010704091202200_bb0110","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jhsa.2010.08.007","article-title":"Injectable collagenase clostridium histolyticum: A new nonsurgical treatment for Dupuytren\u2019s disease","volume":"35","author":"Gilpin","year":"2010","journal-title":"J Hand Surg [Am]"},{"issue":"suppl 8","key":"2023010704091202200_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0363-5023(12)60020-3","article-title":"Histology of cords from Dupuytren\u2019s patients: A comparison after collagenase injection\/fasciectomy, primary fasciectomy and repeat fasciectomy [abstract]","volume":"37","author":"Badalamente","year":"2012","journal-title":"J Hand Surg [Am]"},{"key":"2023010704091202200_bb0120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/1753193413488305","article-title":"Surgical findings in the treatment of Dupuytren\u2019s disease after initial treatment with clostridial collagenase (Xiaflex)","volume":"39","author":"Hay","year":"2013","journal-title":"J Hand Surg Eur Vol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515308936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515308936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/12\/1\/259\/48475425\/jsm_12_1_259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/12\/1\/259\/48475425\/jsm_12_1_259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T23:20:53Z","timestamp":1673047253000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/12\/1\/259\/6966660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,1,1]]},"published-print":{"date-parts":[[2015,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jsm.12721","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725070947.793523278","asserted-by":"object"}]},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,1]]},"published":{"date-parts":[[2015,1,1]]}}}